Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 0.1 mg/ml (equivalent: desmopressin, qty 0.089 mg/ml) - spray, solution - excipient ingredients: dibasic sodium phosphate dihydrate; citric acid monohydrate; sodium chloride; purified water; benzalkonium chloride - diabetes insipidus:the treatment of adh-sensitive cranial diabetes insipidus, including treatment of post-hypophysectomy polydipsia and polyuria.,nocturnal enuresis: minirin nasal spray is indicated for the symptomatic treatment of primary nocturnal enuresis in patients who have normal ability to concentrate urine. minirin nasal spray should be used only in patients who are refractory to the enuresis alarm or in patients in whom enuresis alarm is contraindicated or inappropriate, and where the oral administration of desmopressin is not feasible.,renal concentrating capacity: by intranasal administration to adults and children as a diagnostic test to establish renal concentrating capacity.

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 4 microgram/ml (equivalent: desmopressin, qty 3.56 microgram/ml) - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - diabetes insipidus: the treatment of adh sensitive cranial diabetes insipidus, including treatment of post hypophysectomy polydipsia and polyuria.,renal concentrating capacity: by intramuscular administration to adults only, as a diagnostic test to establish renal concentrating capacity.,mild and moderate haemophillia a and von willebrand?s disease: by intravenous infusion only, for the increase of factor viii levels in patients undergoing dental or minor surgery. not to be used in type iib von willebrand?s disease since platelet aggregation may be induced.,bleeding in patients with platelet dysfunction: treatment of excessive bleeding in patients with congenital or acquired clinical conditions associated with platelet dysfunction which is characterised by a prolonged bleeding time except glanzmann?s thrombasthenia or platelet cyclo-oxygenase deficiency.,examples are patients with uraemia, congenital or drug induced platelet dysfunction and patients undergoing cardiac surgery with cardiopulmonary bypass for p

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate -

Canada - English - Health Canada

teva canada limited - indomethacin - suppository - 100mg - indomethacin 100mg - other nonsteroidal antiimflammatory agents

Australia - English - Department of Health (Therapeutic Goods Administration)

ferring pharmaceuticals pty ltd - desmopressin acetate, quantity: 15 microgram/ml (equivalent: desmopressin, qty 13.4 microgram/ml) - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - mild and moderate haemophillia a and von willebrand?s disease: by intravenous infusion only, for the increase of factor viii levels in patients undergoing dental or minor surgery. not to be used in type iib von willebrand?s disease since platelet aggregation may be induced.,bleeding in patients with platelet dysfunction: treatment of excessive bleeding in patients with congenital or acquired clinical conditions associated with platelet dysfunction which is characterised by a prolonged bleeding time except glanzmann?s thrombasthenia or platelet cyclo-oxygenase deficiency.,examples are patients with uraemia, congenital or drug induced platelet dysfunction and patients undergoing cardiac surgery with cardiopulmonary bypass for prosthetic valve replacement or aorto-coronary bypass grafting especially when it is complicated by platelet function defects sufficient to prolong bleeding time despite relatively normal platelet cover. desmopressin acetate offers no benefit as routine therapy in patients having an uncomp

Canada - English - Health Canada

teva canada limited - desmopressin acetate - tablet - 0.1mg - desmopressin acetate 0.1mg - pituitary

Canada - English - Health Canada

teva canada limited - desmopressin acetate - tablet - 0.2mg - desmopressin acetate 0.2mg - pituitary

Malta - English - Malta Medicines Authority

ferring pharmaceuticals limited - desmopressin acetate 0.1 mg - tablet

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - desmopressin acetate - oral tablet - 200microgram

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

ferring pharmaceuticals ltd - desmopressin acetate - oral tablet - 100microgram